SCHEMBL593294

SCHEMBL593294

COc1cnc2cccc(C=CC(=O)O)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
MAPK1 P28482 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MTNR1B P49286 7/20 0.49
MTNR1A P48039 5/20 0.49
GAA P10253 2/20 0.48
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
RAB9A P51151 1/20 0.44
RHOA P61586 1/20 0.44
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.43
ATM Q13315 1/20 0.43
F2 P00734 1/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
LMNA P02545 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL593293 1.00 KDM4E (0.53) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL592287 0.81 KDM4E (0.80) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL592288 0.81 KDM4E (0.80) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL3244529 0.80 MTNR1B (0.49) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL13652275 0.78 KDM4E (0.52) KDM4EMAPK1NPSR1GAAKEAP1
SCHEMBL3781125 0.77 MTNR1B (0.46) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL7009575 0.77 MTNR1A (0.66) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL7009577 0.77 MTNR1A (0.66) KDM4EMAPK1NPSR1MTNR1BMTNR1A
SCHEMBL16831751 0.75 THRB (0.46) KDM4EMAPK1GAAALDH1A1THRB
SCHEMBL16831750 0.75 THRB (0.46) KDM4EMAPK1GAAALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146987-B1 OXAZOLIDINONE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2015-12-02 EP disclosed
US-8114867-B2 Oxazolidinone antibiotic derivatives ACTELION PHARMACEUTICALS LTD (CH) 2012-02-14 US disclosed
US-20100137290-A1 OXAZOLIDINONE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2010-06-03 US disclosed
EP-2146987-A2 OXAZOLIDINONE ANTIBIOTIC DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2010-01-27 EP disclosed
WO-2008126024-A2 OXAZOLIDINONE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137290-A1 OXAZOLIDINONE ANTIBIOTIC DERIVATIVES OXA1L, XDH, CCNY KDM4E 1842/4885MAPK1 2466/4885NPSR1 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.